Although corneal cross-linking (CXL) for keratoconus is increasingly applied, there is limited evidence on the costs of this treatment. One cost-effectiveness study estimated the costs of the total CXL treatment for one simulated patient as £928 ($1,392 U.S.).
institution, the surgical procedure is performed by an optometrist, as are parts of the preoperative and postoperative consultation. The investment of medical specialist time is therefore reduced. If all care would be delivered by an ophthalmologist, the costs of the treatment itself would increase by 23.5% and the overall cost by 20.3% (calculations not shown). Accelerated CXL has been shown to produce similar results with shorter ultraviolet-A radiation times and thus shorter surgical procedure times. 5 A decreased radiation time from 30 to 5 minutes would save €141.09 or $155.20 (8.0% of total costs and 19.6% of CXL treatment costs). The relatively small decrease is explained by the fact that the majority of costs are incurred during the preoperative consultations and postoperative follow-up period. More detailed insight is provided in Table A . This table can also be used to adjust wages and material costs to local situations. These results provide insight in the financial side of CXL treatment and can be used in health economic evaluations, procedural pricing, and reimbursement negotiations. 
